ALS is a progressive neurodegenerative disease that currently has no cure. Commonly known as Lou Gehrig’s disease, ALS ...

Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated i ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological conditions, announced today that the Company has initiated the ...

He stated that the vaccine sceptic will "help make America healthy again" by protecting ... Bain Capital has agreed to buy Mitsubishi Tanabe for around $3.4 bn, setting up one of the largest ...

The verdict continues a run of setbacks for the pharma industry in its efforts ... Bain Capital has agreed to buy Mitsubishi Tanabe for around $3.4 bn, setting up one of the largest private ...

ArcelorMittal S.A. (Luxembourg) announced that it is proceeding with plans to build an advanced, non-grain-oriented electrical steel (NOES) manufacturing ...

Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...

Bain Capital, a global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma ...

Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit, adding to a dealmaking boom in Japan. The deal values Mitsubishi Tanabe Pharma at about ¥510 ...